Matches in SemOpenAlex for { <https://semopenalex.org/work/W2808880125> ?p ?o ?g. }
- W2808880125 endingPage "846" @default.
- W2808880125 startingPage "839" @default.
- W2808880125 abstract "Notwithstanding the combination of cholinesterase (ChE) inhibition and calcium channel blockade within a multitarget therapeutic approach is envisaged as potentially beneficial to confront Alzheimer's disease (AD), this strategy has been scarcely investigated. To explore this promising line, a series of 5-amino-4-aryl-3,4,6,7,8,9-hexahydropyrimido [4,5-b]quinoline-2(1H)-thiones (tacripyrimidines) (4a-l) were designed by juxtaposition of tacrine, a ChE inhibitor (ChEI), and 3,4-dihydropyrimidin-2(1H)-thiones, as efficient calcium channel blockers (CCBs). In agreement with their design, all tacripyrimidines, except the unsubstituted parent compound and its p-methoxy derivative, acted as moderate to potent CCBs with activities generally similar or higher than the reference CCB drug nimodipine and were modest-to-good ChEIs. Most interestingly, the 3′-methoxy derivative (4e) emerged as the first well balanced ChEI/CCB agent, acting as low micromolar hChEI (3.05 μM and 3.19 μM on hAChE and hBuChE, respectively) and moderate CCB (30.4% at 1 μM) with no significant hepatotoxicity toward HepG2 cells and good predicted oral absorption and blood brain barrier permeability." @default.
- W2808880125 created "2018-06-29" @default.
- W2808880125 creator A5008724133 @default.
- W2808880125 creator A5027321643 @default.
- W2808880125 creator A5032016003 @default.
- W2808880125 creator A5039672667 @default.
- W2808880125 creator A5041836281 @default.
- W2808880125 creator A5041883193 @default.
- W2808880125 creator A5043911386 @default.
- W2808880125 creator A5044493452 @default.
- W2808880125 creator A5056112838 @default.
- W2808880125 creator A5059255858 @default.
- W2808880125 creator A5065109578 @default.
- W2808880125 creator A5069833831 @default.
- W2808880125 creator A5080480131 @default.
- W2808880125 creator A5082905681 @default.
- W2808880125 creator A5085206351 @default.
- W2808880125 date "2018-07-01" @default.
- W2808880125 modified "2023-10-14" @default.
- W2808880125 title "Tacripyrimidines, the first tacrine-dihydropyrimidine hybrids, as multi-target-directed ligands for Alzheimer's disease" @default.
- W2808880125 cites W1417309998 @default.
- W2808880125 cites W1529339318 @default.
- W2808880125 cites W176570333 @default.
- W2808880125 cites W1940331911 @default.
- W2808880125 cites W1969661421 @default.
- W2808880125 cites W1971048984 @default.
- W2808880125 cites W1979683764 @default.
- W2808880125 cites W1981775239 @default.
- W2808880125 cites W1996894861 @default.
- W2808880125 cites W2000837493 @default.
- W2808880125 cites W2025022665 @default.
- W2808880125 cites W2039069312 @default.
- W2808880125 cites W2039402692 @default.
- W2808880125 cites W2050025660 @default.
- W2808880125 cites W2051044968 @default.
- W2808880125 cites W2058974479 @default.
- W2808880125 cites W2063188901 @default.
- W2808880125 cites W2064257641 @default.
- W2808880125 cites W2065515412 @default.
- W2808880125 cites W2071180837 @default.
- W2808880125 cites W2072219894 @default.
- W2808880125 cites W2073887042 @default.
- W2808880125 cites W2075304800 @default.
- W2808880125 cites W2084107396 @default.
- W2808880125 cites W2085377099 @default.
- W2808880125 cites W2085736167 @default.
- W2808880125 cites W2085753116 @default.
- W2808880125 cites W2097391583 @default.
- W2808880125 cites W2100061207 @default.
- W2808880125 cites W2105512157 @default.
- W2808880125 cites W2106605095 @default.
- W2808880125 cites W2122429894 @default.
- W2808880125 cites W2135732933 @default.
- W2808880125 cites W2142093490 @default.
- W2808880125 cites W2160250661 @default.
- W2808880125 cites W2227380982 @default.
- W2808880125 cites W2252542094 @default.
- W2808880125 cites W2289453788 @default.
- W2808880125 cites W2317110841 @default.
- W2808880125 cites W2337884630 @default.
- W2808880125 cites W2401678552 @default.
- W2808880125 cites W2463644552 @default.
- W2808880125 cites W2519882335 @default.
- W2808880125 cites W2542856291 @default.
- W2808880125 cites W2617072792 @default.
- W2808880125 cites W2683272387 @default.
- W2808880125 cites W2707932262 @default.
- W2808880125 cites W2765584833 @default.
- W2808880125 doi "https://doi.org/10.1016/j.ejmech.2018.06.044" @default.
- W2808880125 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29958119" @default.
- W2808880125 hasPublicationYear "2018" @default.
- W2808880125 type Work @default.
- W2808880125 sameAs 2808880125 @default.
- W2808880125 citedByCount "40" @default.
- W2808880125 countsByYear W28088801252018 @default.
- W2808880125 countsByYear W28088801252019 @default.
- W2808880125 countsByYear W28088801252020 @default.
- W2808880125 countsByYear W28088801252021 @default.
- W2808880125 countsByYear W28088801252022 @default.
- W2808880125 countsByYear W28088801252023 @default.
- W2808880125 crossrefType "journal-article" @default.
- W2808880125 hasAuthorship W2808880125A5008724133 @default.
- W2808880125 hasAuthorship W2808880125A5027321643 @default.
- W2808880125 hasAuthorship W2808880125A5032016003 @default.
- W2808880125 hasAuthorship W2808880125A5039672667 @default.
- W2808880125 hasAuthorship W2808880125A5041836281 @default.
- W2808880125 hasAuthorship W2808880125A5041883193 @default.
- W2808880125 hasAuthorship W2808880125A5043911386 @default.
- W2808880125 hasAuthorship W2808880125A5044493452 @default.
- W2808880125 hasAuthorship W2808880125A5056112838 @default.
- W2808880125 hasAuthorship W2808880125A5059255858 @default.
- W2808880125 hasAuthorship W2808880125A5065109578 @default.
- W2808880125 hasAuthorship W2808880125A5069833831 @default.
- W2808880125 hasAuthorship W2808880125A5080480131 @default.
- W2808880125 hasAuthorship W2808880125A5082905681 @default.
- W2808880125 hasAuthorship W2808880125A5085206351 @default.
- W2808880125 hasConcept C178790620 @default.
- W2808880125 hasConcept C181199279 @default.